QCM
WVE icon

Quantinno Capital Management’s Wave Life Sciences WVE Stock Holding History

Quantinno Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180K Sell
30,928
-16,957
-35% -$112K ﹤0.01% 3353
2026
Q1 		$347K Buy
47,885
+8,960
+23% +$117K ﹤0.01% 2953
2025
Q4 		$662K Sell
38,925
-6,124
-14% -$62.2K ﹤0.01% 2138
2025
Q3 		$330K Buy
+45,049
New +$364K ﹤0.01% 2384

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Quantinno Capital Management's WVE Position: Q2 2026 in Review

Quantinno Capital Management reduced its Wave Life Sciences (WVE) stake by 35% in Q2 2026, selling an estimated $112K and leaving 30,928 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #3353.

Quantinno Capital Management first reported a position in WVE in Q3 2025 and has held it in 4 quarters since. The position peaked at $662K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Quantinno Capital Management held 30,928 shares of Wave Life Sciences worth $180K as of Q2 2026.
  • Quantinno Capital Management sold 16,957 Wave Life Sciences shares in Q2 2026, an estimated $112K.
  • Wave Life Sciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3353 holding.
  • Quantinno Capital Management first reported a position in Wave Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • Quantinno Capital Management's Wave Life Sciences position peaked at $662K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.